Cargando…
Apatinib in Combination with S‐1 as First‐Line Treatment in Patients with Advanced Metastatic Gastric Cancer: Results from an Open, Exploratory, Single‐Arm, Phase II Trial
LESSONS LEARNED: Apatinib combined with S‐1 was not superior to other chemotherapy regimens as first‐line therapy for advanced gastric cancer. There was a tendency for patients with lymph node metastasis to have prolonged median progression‐free survival and median overall survival, compared with pa...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930411/ https://www.ncbi.nlm.nih.gov/pubmed/33244809 http://dx.doi.org/10.1002/onco.13613 |